Related Experiment Video
Updated: Jun 17, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
[Coxsackievirus A group 16 strain]
Zhao-Hui Yang1, Shao-Fu Yin, Zong-Jiu Zhang
1State Key Laboratory for Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Insights
Understanding Coxsackievirus A group 16 (CVA16) is crucial for controlling hand, foot, and mouth disease (HFMD). Further research and improved diagnostics will aid in prevention and vaccine development.
Area of Science:
- Virology
- Epidemiology
- Public Health
Context:
- Coxsackievirus A group 16 (CVA16) is a primary cause of hand, foot, and mouth disease (HFMD).
- Understanding CVA16's biology is vital for disease control.
Purpose:
- To review the biological characteristics, pathogenesis, clinical features, diagnosis, and epidemiology of CVA16.
- To highlight areas for future research and intervention strategies.
Summary:
- CVA16 infection requires comprehensive understanding of its biological traits, disease mechanisms, and clinical presentation.
- Current diagnostic methods and epidemiological surveillance need enhancement.
- Future efforts should focus on improved diagnostics, vaccine development, and robust monitoring networks.
Impact:
- Enhanced understanding of CVA16 will improve HFMD prevention and control strategies.
- Development of better diagnostic tools and vaccines is essential.
- Establishing integrated epidemiological and laboratory surveillance networks will aid in predicting and mitigating CVA16 outbreaks.
Abstract:
Coxsackievirus A group 16 strain (CVA16) is one of the predominate causative agent of the hand, foot and mouth disease (HFHD). It is very helpful to improve the hand, foot and mouth disease and other associated diseases control and prevention by understanding its biological characteristics, pathogenic mechanism and clinical manifestations, laboratory diagnoses, epidemiology and molecular epidemiology. In the future, we should continue to emphasize the study, improve the diagnostic method and develop vaccine of CVA16. A sound monitoring network of both epidemiology and laboratory will be estabished as well, which can contribute to predicting and prewarning the epidemic conditions of CVA16, and is much important scientific tools for preventing the hand, foot and mouth disease associated with CVA16.
Related Concept Videos
Bacterial Gastroenteritis
Streptococcal Pharyngitis
Cytomegalovirus Disease
Arboviral Encephalitis
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis

